These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2311809)

  • 21. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metergoline in the inhibition of puerperal lactation.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    Br Med J; 1977 Mar; 1(6063):744-6. PubMed ID: 322792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combined oral contraceptive pill versus bromocriptine to suppress lactation in puerperium: a randomized double blind study.
    Piya-Anant M; Worapitaksanond S; Sittichai K; Saechua P; Nomrak A
    J Med Assoc Thai; 2004 Jun; 87(6):670-3. PubMed ID: 15279347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma prolactin and puerperal blood pressure.
    Jenkins DM; Soltan MH
    Br J Obstet Gynaecol; 1980 Jul; 87(7):597-9. PubMed ID: 7426514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154).
    Macleod SC; Scott J; Lord L; Brodie G; Perlin I; Simpson AA
    Clin Endocrinol (Oxf); 1977; 6 Suppl():65S-70S. PubMed ID: 617072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation.
    Shapiro AG; Thomas L
    South Med J; 1984 Jun; 77(6):719-21. PubMed ID: 6729548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal spray administration of bromocriptine: pharmacology and effect on serum prolactin level in puerperal women.
    Cicinelli E; Cignarelli M; Petruzzi D; Matteo G; Ruccia C; Schonauer LM
    Gynecol Endocrinol; 1996 Dec; 10(6):391-6. PubMed ID: 9032565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prolactin and the suppression of lactation.
    Weinstein D; Ben-David M; Polishuk WZ
    Br J Obstet Gynaecol; 1976 Sep; 83(9):679-82. PubMed ID: 788774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study.
    Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal spray bromocriptine: effects on serum prolactin in puerperal women.
    Cicinelli E; Petruzzi D; Ragno G; Schönauer LM; Ruccia C; Matteo G
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):730-3. PubMed ID: 8906007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral cabergoline. Single-dose inhibition of puerperal lactation.
    Caballero-Gordo A; Lopez-Nazareno N; Calderay M; Caballero JL; Mancheño E; Sghedoni D
    J Reprod Med; 1991 Oct; 36(10):717-21. PubMed ID: 1683403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of puerperal lactation using bromocryptin].
    Gibelli B
    Riv Ital Ginecol; 1977; 58(4):347-53. PubMed ID: 756602
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of puerperal lactation with bromocriptine, a report].
    Zubke W; Neeser E; Peters FD; Roemer VM
    Arch Gynecol; 1979 Jul; 228(1-4):586-7. PubMed ID: 485488
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory effects of bromocriptine on mammary development and function in lactating mice.
    Knight CH; Calvert DT; Flint DJ
    J Endocrinol; 1986 Aug; 110(2):263-70. PubMed ID: 3746163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study].
    Brue T; James-Deidier A; Louvet JP; Dewailly D; Roger P; Schlienger JL; Schaison G; Hartemann P; Jaquet P
    Ann Endocrinol (Paris); 1991; 52(4):273-82. PubMed ID: 1818531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.